title: Hepatitis C virus infection and related liver disease: the quest for the best animal model.
abstract: Hepatitis C virus (HCV) is a major cause of cirrhosis and hepatocellular carcinoma (HCC) making the virus the most common cause of liver failure and transplantation. HCV is estimated to chronically affect 130 million individuals and to lead to more than 350,000 deaths per year worldwide. A vaccine is currently not available. The recently developed direct acting antivirals (DAAs) have markedly increased the efficacy of the standard of care but are not efficient enough to completely cure all chronically infected patients and their toxicity limits their use in patients with advanced liver disease, co-morbidity or transplant recipients. Because of the host restriction, which is limited to humans and non-human primates, in vivo study of HCV infection has been hampered since its discovery more than 20 years ago. The chimpanzee remains the most physiological model to study the innate and adaptive immune responses, but its use is ethically difficult and is now very restricted and regulated. The development of a small animal model that allows robust HCV infection has been achieved using chimeric liver immunodeficient mice, which are therefore not suitable for studying the adaptive immune responses. Nevertheless, these models allowed to go deeply in the comprehension of virus-host interactions and to assess different therapeutic approaches. The immunocompetent mouse models that were recently established by genetic humanization have shown an interesting improvement concerning the study of the immune responses but are still limited by the absence of the complete robust life cycle of the virus. In this review, we will focus on the relevant available animal models of HCV infection and their usefulness for deciphering the HCV life cycle and virus-induced liver disease, as well as for the development and evaluation of new therapeutics. We will also discuss the perspectives on future immunocompetent mouse models and the hurdles to their development.
authors.affiliation: Inserm U1110, Université de Strasbourg Strasbourg, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Mailly
authors.forename: Eric
authors.initials: E
authors.lastname: Robinet
authors.forename: Philip
authors.initials: P
authors.lastname: Meuleman
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Baumert
authors.forename: Mirjam B
authors.initials: MB
authors.lastname: Zeisel
keywords: animal models; antivirals; hepatitis C virus; hepatocellular carcinoma; immunocompetent mouse model; liver disease
references.citation: PLoS Pathog. 2010 Jul 01;6:e1000978
references.pmid: 20617177
references.citation: Gut. 2013 Sep;62(9):1340-6
references.pmid: 23135762
references.citation: Cell Host Microbe. 2009 Jul 23;6(1):5-9
references.pmid: 19616761
references.citation: J Virol. 2011 Mar;85(6):2793-802
references.pmid: 21177818
references.citation: Am J Pathol. 2004 Sep;165(3):901-12
references.pmid: 15331414
references.citation: J Virol. 2010 Jan;84(1):303-11
references.pmid: 19846521
references.citation: Cell. 1991 Jul 26;66(2):245-56
references.pmid: 1713128
references.citation: J Interferon Cytokine Res. 1999 May;19(5):533-41
references.pmid: 10386866
references.citation: Curr Top Microbiol Immunol. 2013;369:1-15
references.pmid: 23463195
references.citation: Gut. 2013 Jul;62(7):1055-61
references.pmid: 23322441
references.citation: Gastroenterology. 2005 May;128(5):1416-23
references.pmid: 15887122
references.citation: Altern Lab Anim. 2010 Oct;38(5):387-418
references.pmid: 21105756
references.citation: Int Immunopharmacol. 2013 Aug;16(4):466-74
references.pmid: 23669332
references.citation: Immunol Rev. 2011 Jan;239(1):99-108
references.pmid: 21198667
references.citation: Nat Immunol. 2007 Dec;8(12):1287-9
references.pmid: 18026079
references.citation: Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13218-23
references.pmid: 21788509
references.citation: Mol Cell Proteomics. 2013 Mar;12(3):710-9
references.pmid: 23264353
references.citation: J Hepatol. 2013 Feb;58(2):375-84
references.pmid: 23041307
references.citation: Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13224-9
references.pmid: 21788504
references.citation: Immunity. 2007 May;26(5):537-41
references.pmid: 17521579
references.citation: Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):341-52
references.pmid: 21651352
references.citation: Nat Immunol. 2007 Dec;8(12):1313-23
references.pmid: 17982459
references.citation: J Hepatol. 2011 May;54(5):872-8
references.pmid: 21145818
references.citation: Br J Haematol. 1998 Nov;103(2):335-42
references.pmid: 9827902
references.citation: Nat Genet. 2009 Oct;41(10):1100-4
references.pmid: 19749758
references.citation: Emerg Infect Dis. 2012 Dec;18(12):1976-82
references.pmid: 23171728
references.citation: J Virol. 2006 Aug;80(15):7364-74
references.pmid: 16840317
references.citation: Nature. 2005 Aug 18;436(7053):946-52
references.pmid: 16107834
references.citation: Curr Top Microbiol Immunol. 2008;324:53-76
references.pmid: 18481452
references.citation: Nature. 2009 Sep 17;461(7262):399-401
references.pmid: 19684573
references.citation: Hepatology. 2012 Feb;55(2):364-72
references.pmid: 21953761
references.citation: Nature. 2009 Feb 12;457(7231):882-6
references.pmid: 19182773
references.citation: Proc Natl Acad Sci U S A. 2013 May 14;110(20):8194-9
references.pmid: 23610427
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3805-9
references.pmid: 16484368
references.citation: Sci Transl Med. 2011 May 11;3(82):82ra39
references.pmid: 21562231
references.citation: Nat Biotechnol. 2007 Aug;25(8):903-10
references.pmid: 17664939
references.citation: Gastroenterology. 2009 Aug;137(2):673-81
references.pmid: 19394333
references.citation: Virology. 1998 May 10;244(2):513-20
references.pmid: 9601519
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20507-11
references.pmid: 18077355
references.citation: J Clin Invest. 2002 Jan;109(2):221-32
references.pmid: 11805134
references.citation: PLoS Pathog. 2006 Jun;2(6):e59
references.pmid: 16789836
references.citation: J Immunol. 2004 Mar 1;172(5):2731-8
references.pmid: 14978070
references.citation: Genes Dev. 1993 Dec;7(12A):2298-307
references.pmid: 8253378
references.citation: Gastroenterology. 2011 Sep;141(3):1057-66
references.pmid: 21699799
references.citation: Gastroenterology. 2010 Sep;139(3):965-74
references.pmid: 20621699
references.citation: Gastroenterology. 2011 Apr;140(4):1334-44
references.pmid: 21237170
references.citation: Eur J Immunol. 2004 Nov;34(11):3060-9
references.pmid: 15468058
references.citation: Hepatology. 2004 Jun;39(6):1469-75
references.pmid: 15185284
references.citation: J Virol. 1995 Sep;69(9):5621-30
references.pmid: 7637008
references.citation: Hepatology. 2011 Mar;53(3):755-62
references.pmid: 21319203
references.citation: Hepatology. 2005 Apr;41(4):847-56
references.pmid: 15791625
references.citation: J Gen Virol. 2007 Sep;88(Pt 9):2504-2512
references.pmid: 17698660
references.citation: J Viral Hepat. 2012 Jul;19(7):449-64
references.pmid: 22676357
references.citation: Nat Genet. 1996 Mar;12(3):266-73
references.pmid: 8589717
references.citation: J Infect Dis. 2010 May 1;201(9):1381-9
references.pmid: 20353362
references.citation: Hepatology. 2011 May;53(5):1742-51
references.pmid: 21374691
references.citation: Hepatology. 2011 Oct;54(4):1135-48
references.pmid: 21674561
references.citation: Lab Anim (NY). 2012 Jan 20;41(2):31
references.pmid: 22261878
references.citation: World J Gastroenterol. 2001 Jun;7(3):324-30
references.pmid: 11819784
references.citation: Gastroenterology. 2007 Oct;133(4):1144-55
references.pmid: 17919490
references.citation: Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2544-8
references.pmid: 22308485
references.citation: Virol J. 2006 Oct 28;3:89
references.pmid: 17069661
references.citation: J Virol. 2013 May;87(10):5554-63
references.pmid: 23468504
references.citation: Intervirology. 2001;44(2-3):132-42
references.pmid: 11509874
references.citation: J Virol. 2003 Apr;77(8):4781-93
references.pmid: 12663785
references.citation: PLoS One. 2011;6(6):e21284
references.pmid: 21731692
references.citation: Nat Med. 2001 Aug;7(8):927-33
references.pmid: 11479625
references.citation: Nat Med. 2008 Jan;14(1):25-7
references.pmid: 18064037
references.citation: Nat Genet. 1995 Aug;10(4):453-60
references.pmid: 7545495
references.citation: Blood. 2013 Feb 21;121(8):1316-25
references.pmid: 23293079
references.citation: Nat Med. 2005 Jul;11(7):797-803
references.pmid: 15965483
references.citation: PLoS Pathog. 2011 Apr;7(4):e1002029
references.pmid: 21552323
references.citation: Biomed Res. 2011 Apr;32(2):143-50
references.pmid: 21551950
references.citation: Mol Imaging. 2003 Oct;2(4):297-302
references.pmid: 14717328
references.citation: J Virol. 2005 May;79(9):5774-85
references.pmid: 15827192
references.citation: Hepatology. 2009 Mar;49(3):745-52
references.pmid: 19072827
references.citation: Virology. 2013 Sep;444(1-2):1-11
references.pmid: 23777661
references.citation: Hepatology. 2008 Jun;47(6):1846-55
references.pmid: 18452146
references.citation: J Virol. 2012 Jun;86(11):6171-8
references.pmid: 22491452
references.citation: J Hepatol. 2010 Sep;53(3):468-76
references.pmid: 20591528
references.citation: Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11608-13
references.pmid: 21610165
references.citation: Nat Biotechnol. 2003 May;21(5):519-25
references.pmid: 12704395
references.citation: Curr Top Microbiol Immunol. 2013;369:49-86
references.pmid: 23463197
references.citation: PLoS Pathog. 2012;8(4):e1002617
references.pmid: 22496645
references.citation: Antivir Ther. 2012;17(6 Pt B):1147-62
references.pmid: 23188771
references.citation: J Clin Invest. 2009 Jul;119(7):1745-54
references.pmid: 19587449
references.citation: J Med Chem. 2011 Jan 13;54(1):289-301
references.pmid: 21141896
references.citation: Curr Top Microbiol Immunol. 2013;369:219-42
references.pmid: 23463203
references.citation: Nature. 2011 May 11;475(7356):386-9
references.pmid: 21562492
references.citation: J Clin Invest. 2010 Mar;120(3):924-30
references.pmid: 20179355
references.citation: FEBS Lett. 2007 May 15;581(10):1983-7
references.pmid: 17466983
references.citation: Nature. 2011 Jun 29;475(7356):390-3
references.pmid: 21716291
references.citation: J Med Primatol. 1988;17(5):235-46
references.pmid: 3148034
references.citation: Biochem Biophys Res Commun. 2007 Feb 23;353(4):882-8
references.pmid: 17196931
references.citation: Antimicrob Agents Chemother. 2011 Nov;55(11):5159-67
references.pmid: 21896910
references.citation: J Virol. 2003 Sep;77(17):9204-10
references.pmid: 12915536
references.citation: Nat Med. 2011 May;17(5):589-95
references.pmid: 21516087
references.citation: J Virol. 2010 Sep;84(18):9170-80
references.pmid: 20592082
references.citation: Hepatology. 2005 Apr;41(4):832-5
references.pmid: 15732092
references.citation: J Hepatol. 2012 Jul;57(1):17-23
references.pmid: 22414763
references.citation: Gastroenterology. 2013 Aug;145(2):447-55.e1-4
references.pmid: 23673355
references.citation: J Hepatol. 2009 Nov;51(5):939-48
references.pmid: 19781804
references.citation: J Gen Virol. 2010 Jul;91(Pt 7):1668-77
references.pmid: 20164258
references.citation: Trends Immunol. 2011 Jul;32(7):321-7
references.pmid: 21697012
references.citation: Nat Genet. 2009 Oct;41(10):1105-9
references.pmid: 19749757
references.citation: Nature. 2011 Jun 08;474(7350):208-11
references.pmid: 21654804
references.citation: Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3401-5
references.pmid: 7724574
references.citation: J Clin Invest. 2010 Sep;120(9):3120-6
references.pmid: 20739754
references.citation: Mol Ther. 2002 Jun;5(6):676-84
references.pmid: 12027551
references.citation: Curr Top Microbiol Immunol. 2013;369:243-62
references.pmid: 23463204
references.citation: ILAR J. 2001;42(2):117-26
references.pmid: 11406714
references.citation: Hepatology. 2008 Dec;48(6):1761-8
references.pmid: 19030166
references.citation: Nat Med. 2012 Jan 08;18(2):281-5
references.pmid: 22231557